Nanovex Biotechnologies SL performs R&D internal projects to improve, innovate or expand our portfolio of products and services.
In addition, our company participates and collaborates with other companies, universities and research centers in R&D projects carried out both by public funding, through calls for national and international organizations, and private funding.
Some of the projects funded by public organizations in which Nanovex Biotechnologies participates or has participated:
- Design and development of new nanomaterial-based products for use in bioassays and flow citometry
- Adaptation of the process to obtain new products based on nanomaterials
- Integración de un sistema de microalgas, extracción y nanoencapsulación de compuestos de alto valor añadido para producir productos cárnicos saludables
COLLABORATION OFFER FOR HORIZON 2020 CALLS
2018 – 2020
Nanovex Biotechnologies SL is a Spanish SME specialized in the design&development of nanovesicles, nanocapsules and inorganic nanoparticles for multiple applications. The company participates in various national and international research & innovation projects. Company is opened to offer their expertise for the Horizon2020 calls 2018 – 2020, presented on the following table.
Contact information email@example.com
|Osteoarticular tissues regeneration (RIA)||Bioactive compound encapsulation in polymeric nanocapsules to improve the tissue regeneration|
|6 february 2018|
Theranostic delivery systems,
Extracellular Vesicles detection, drug delivery systems
|SC1-BHC-15-2018||6 february 2018|
|New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)||Bioconjugated nanovesicles and metallic nanoparticles, drug delivery systems, diagnostics|
|SC1-BHC-09-2018||18 April 2018||Innovation platforms for advanced therapies of the future||Magnetic Nanoparticles,|
|Personalised Medicine- Preclincal research||Drug encapsulation; new theranostic systems, Customized nanoparticles development|
Organisation: Nanovex Biotechnologies SL
Location: Parque Tecnológico de Asturias (SPAIN)
Institutional status: Medium-sized enterprise (SME)
Area of activities: Provider of nanobiotechnological products and services for academia and industry